Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Treatments and challenges for bullous pemphigoid

Systemic corticosteroids and other immunosuppressants are the current mainstay of therapy but carry risks for patients with bullous pemphigoid. Read this article to find out more

Pathophysiology of Bullous Pemphigoid

In bullous pemphigoid, autoimmunity to BP180 and BP230 is thought to trigger a type 2 inflammatory response. Read this article to find out more

Considerations for bullous pemphigoid management

The management of bullous pemphigoid is challenging and new treatment approaches are needed. Read this article to find out more.

Mechanism of Smoldering Disease

Disease Progression Monitoring

BTK Enzyme

Smouldering Disease Burden

Smoldering Disease Detection

Smoldering Disease Overview

Tolebrutinib Direct Effects on Myeloid Cells in PwMS

Inside MS: Explore how BTK drives immune cell activation and CNS damage

Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity